Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals

Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals 4th March 2021

Mawdsleys is delighted to now be partnering with Morningside Pharmaceuticals as an additional distributor to supply their contract and non-contract products to hospitals.

Morningside has a portfolio of 242 generic and branded licensed medicines in the UK and EU and is a proud manufacturer and supplier to NHS Trusts, pharmacy chains, pharmaceutical wholesalers, as well as clinics and dispensing doctors in the UK.

Morningside’s products are available for customers to order now from Mawdsleys.

Other latest news

Tillomed Laboratories choose Mawdsleys as their distributor to hospitals

Mawdsleys are delighted to be assisting Tillomed Laboratories in bringing their injectable products to market (September 2017). We will be distributing CMU contracted products to English hospitals and products with special prices to Scotland, Wales and Northern Ireland: Description: Carmustine Injection Vial 100mg Pack: 100mg PIP Code: 7936438 EAN Code: 008902319061371 Description: Cidofovir…

Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer. Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…